Co-Authors
This is a "connection" page, showing publications co-authored by Erin Hahn and Quyen Ngo-Metzger.
Connection Strength
0.940
-
Locally-tailored vs. centrally-administered strategies for implementation of primary human papillomavirus (HPV) screening in an integrated healthcare system: a qualitative research study. Front Health Serv. 2025; 5:1595934.
Score: 0.244
-
Colorectal Cancer Screening and Social Needs. J Am Board Fam Med. 2025 Jan 02.
Score: 0.235
-
De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening. Implement Sci Commun. 2021 Sep 23; 2(1):108.
Score: 0.187
-
A pragmatic randomized trial to compare strategies for implementing?primary HPV testing for routine cervical cancer screening in a large?healthcare system. Implement Sci. 2025 May 12; 20(1):21.
Score: 0.060
-
Evaluating the trend of time to colposcopy follow-up among women with a positive primary human papillomavirus screening result at Kaiser Permanente Southern California. Am J Obstet Gynecol. 2025 Mar 27.
Score: 0.060
-
Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
Score: 0.058
-
A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
Score: 0.051
-
Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29; 70(4):109-113.
Score: 0.045